Da32 Life Science Tech Acquisition Corp (DALS)
$10.32
$0.00 (0.00%)As on 04-Aug-2023 09:30EDT
Market cap
$264 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
171.7
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$1 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$0.4
-
Face value
--
-
Shares outstanding
20,650,000
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Da32 Life Science Tech Acquisition Corp (DALS)
| 3.3 | 0.6 | 1.3 | 6.1 | -- | -- | -- |
|
BSE Sensex*
| -9.1 | -1.5 | 2.9 | -3.6 | 5.9 | 6.0 | 10.5 |
|
Company
|
2022
|
|---|---|
|
Da32 Life Science Tech Acquisition Corp (DALS)
| 1.9 |
|
BSE Sensex
| 4.4 |
|
BSE Sensex
| 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Da32 Life Science Tech Acquisition Corp (DALS)
|
10.3 | 264.2 | 0.0 | 1.9 | -- | 1 | 171.7 | 0.0 |
| 17.9 | -- | 8.2 | 17.5 | -38.0 | 4.4 | -- | 0.0 | |
| 10.0 | 342.0 | 0.0 | 2.3 | -- | -- | -- | 0.0 | |
| 15.6 | 661.5 | 408.6 | -156.0 | -39.9 | -14.6 | -- | 0.7 | |
| 11.6 | 872.0 | 1,798.1 | -73.6 | 3.2 | -11.5 | -- | 12.9 | |
| 53.8 | 1,855.7 | 0.0 | -21.9 | -- | -8.5 | -- | 7.5 | |
| 13.2 | 947.8 | 313.3 | 56.4 | 17.4 | 17.6 | 7.2 | 2.9 | |
| 22.1 | 425.8 | 43.4 | 0.1 | 3.2 | 0.2 | 2218 | 1.0 | |
| 10.5 | 326.7 | 0.0 | 7.9 | -- | 3.4 | 40.2 | 1.4 | |
| 18.5 | 687.1 | -1,011.8 | 413.8 | 16.0 | 61.2 | -- | 0.8 |
Shareholding Pattern
View DetailsAbout Da32 Life Science Tech Acquisition Corp (DALS)
DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in... the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York. Read more
-
CEO & Director
Dr. Steven Kafka Ph.D.
-
CEO & Director
Dr. Steven Kafka Ph.D.
-
Headquarters
New York, NY
-
Website
--
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Da32 Life Science Tech Acquisition Corp (DALS)
What is the current share price of Da32 Life Science Tech Acquisition Corp (DALS) Today?
The share price of Da32 Life Science Tech Acquisition Corp (DALS) is $10.32 (NASDAQ) as of 04-Aug-2023 09:30 EDT. Da32 Life Science Tech Acquisition Corp (DALS) has given a return of 6.06% in the last 1 years.
What is the current PB & PE ratio of Da32 Life Science Tech Acquisition Corp (DALS)?
The P/E ratio of Da32 Life Science Tech Acquisition Corp (DALS) is 171.67 times as on 04-Aug-2023.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
83.40 |
0.25 |
2021 |
-- |
-- |
2022 |
83.40 |
0.25 |
2021 |
-- |
-- |
What is the 52 Week High and Low of Da32 Life Science Tech Acquisition Corp (DALS)?
The 52-week high and low of Da32 Life Science Tech Acquisition Corp (DALS) are Rs -- and Rs -- as of 01-Sep-2026.
What is the market cap of Da32 Life Science Tech Acquisition Corp (DALS)?
Da32 Life Science Tech Acquisition Corp (DALS) has a market capitalisation of $ 264 Mln as on 04-Aug-2023. As per SEBI classification, it is a company.
Should I invest in Da32 Life Science Tech Acquisition Corp (DALS)?
Before investing in Da32 Life Science Tech Acquisition Corp (DALS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.